News

MedPage Today4h
Finerenone Gets Expanded FDA Approval in Heart Failure
The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.
Public Broadcasting Service (PBS)6h
WATCH LIVE: RFK Jr. makes ‘major announcement’ with FDA and International Dairy Foods Association
Agriculture Secretary Brooke Rollins and Health and Human Services Secretary Robert F. Kennedy Jr. will hold a news briefing ...
Stars Insider on MSN6h
FDA issues alert, recall for contaminated blueberries
On July 1, the FDA upgraded its recall of Alma Pak organic blueberries to Class I—the highest alert—after Listeria ...
GSK seeks FDA nod for expanded use of RSV vaccine in adults
British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...
Healio1h
FDA approves natural color additive gardenia blue, asks for quicker phase-out of Red No. 3
The FDA has approved the natural color additive gardenia (genipin) blue for use in various foods and drinks at “levels ...
FDA approves new blue food dye derived from gardenia fruit
The U.S. Food and Drug Administration approved a new blue color additive derived from the fruit of the gardenia, a flowering ...
Food Dive2h
FDA approves natural blue color, urges accelerated phaseout of synthetic red dye
The White House asked companies to remove Red No. 3, an artificial color in candy and cereal, sooner than the 2027 deadline ...
CNET2h
The FDA Just Approved a New Blue Food Dye: This Is What It's Made Of
Gardenia (genipin) blue is the fourth natural food color additive to be approved by the FDA this year. This is how it's made.
WIVB Buffalo on MSN1h
Roswell Park encouraged by FDA changes to CAR T-Cell Therapy
A Major ‘Yellowstone’ Character Will Reprise His Role in the New Beth and Rip Spin-off Series Gravitational waves reveal most ...
Fierce Pharma7h
Ultragenyx takes another hit as FDA snubs AAV gene therapy over manufacturing issues
The manufacturing-related rejection for UX111 is more than a setback for Ultragenyx, as it also delays a key test of the new ...
STAT9hOpinion
The FDA commissioner is a gifted talker — but the job is about more than that
FDA Commissioner Marty Makary's vision for the agency risks the best of an agency that mostly has functioned well for the ...
Capricor Therapeutics: Buying Opportunity Following FDA's Complete Response Letter
Capricor Therapeutics's dip caused by the CRL is a buying opportunity considering the readout of HOPE-3 within 2-3 months.